HedgePath Pharmaceuticals, Inc. (12) | Intellectual Property (2)
- License Agreements (2 contracts)
- License Agreement by and between the Company and Mayne, dated December 13, 2022 (Filed With SEC on December 19, 2022)
- Third Amended and Restated Supply and License Agreement, dated December 17, 2018, by and among Mayne Pharma, Mayne Pharma International and the Company (Filed With SEC on March 7, 2019)
